Friday, July 11 7:30–9:15am
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 (Part 1)
Friday, July 11 10:15am–12:30pm
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 (Part 2)
Friday, July 11 7:30–9:15am
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 (Part 1)
Friday, July 11 10:15am–12:30pm
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 (Part 2)
Thursday, July 10 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Thursday, July 10 3:30–4:15pm
Friday, July 11 7:30–9:15am
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 (Part 1)
Friday, July 11 10:15am–12:30pm
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 (Part 2)
Friday, July 11 7:30–9:15am
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 (Part 1)
Friday, July 11 10:15am–12:30pm
P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 (Part 2)
Thursday, July 10 2:30–3:30pm
Skin Deep: Tackling Everyday Dermatologic Cases in Primary Care
Thursday, July 10 8:30–9:30am
Brain Check: Promoting Brain Health and Detecting Cognitive Impairment
Friday, July 11 1:45–2:45pm
Pharmacology Updates 2025: New Medications Reshaping Primary Care
Thursday, July 10 8:30–9:30am
Brain Check: Promoting Brain Health and Detecting Cognitive Impairment
Thursday, July 10 7:30–8:30am
Thursday, July 10 10:30–11:30am
Thursday, July 10 4:30–6pm
Taking the Dialogue to the Next Level: Facilitating Open Communication About Obesity
Thursday, July 10 11:30am–12:15pm
Breakthroughs in Psychiatry: Emerging Treatments for Common Disorders
Disclosures
The following financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute. Relevant relationships will be disclosed at the start of each presentation.
Financial Disclosures
- Charles E. Argoff, MD, FABPM
- AbbVie, Researcher; AbbVie, Lilly, Scilex, Lundbeck, Averitas Pharma, Teva, Impel, Kowa Pharmaceuticals, Nevro, Speaker; Collegium, Scilex, Vertex, Xgene Pharma, Tris, PainScripts, Nevro, Consultant; Lundbeck and Teva, Other; Pfizer and Trevana, Stock Holder (publicly traded company)
- Oscar A. de Leon-Casasola, MD
- Merck Pharmaceuticals, Vertex Pharmaceuticals., Consultant
- Lisa M. Ferreira, MD, FOMA
- Elil Lilly and Novo Nordisk Inc., Speaker
- Katherine E. Galluzzi, DO, CMD, FACOFP
- Lilly, Advisor
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- OptumRx, Consultant; Premier, Inc., Consultant
- Aubrey J. Grant, MD, FACC
- No relevant financial relationships disclosed.
- Avery Lachance, MD, MPH
- Guidepoint, Consultant; J&J, Consultant; Merck, Researcher; Pfizer, Consultant; Pfizer, Researcher; TD Cowen, Advisor
- Vani Potluri, MD
- No relevant financial relationships disclosed
- Philip Schoenfeld, MD, MSEd, MSc
- Ironwood Pharmaceuticals, Ardelyx Pharmaceuticals, Phathom Pharmaceuticals, AbbVie Pharmaceuticals, Speaker; Phathom Pharmaceuticals, Ardelyx Pharmaceuticals, Consultant
- Chrisandra L. Shufelt, MD, MS, FACP, MSCP
- Bayer, Novo Nordisk, Advisor
- Pierre N. Tariot, MD
- AbbVie, Athira, Cognition Therapeutics, Advisor; Acadia, Bristol Myers-Squibb, Corium, ImmunoBrain, Janssen, Maplight, Novartis, Consultant; Astellas, Speaker; Eli Lilly, Novo Nordisk, Stock Holder (publicly traded company)
- Charles Vega, MD, FAAFP
- Boehringer Ingelheim, and Exact Sciences, Consultant
- Shirah Vollmer, MD
- No relevant financial relationships disclosed
Other Disclosures
Pamela Kushner, MD, FAAFP (Reviewer): Speaker and Advisor for AstraZeneca, Boehringer Ingelheim, Corcept, GSK, Haleon, and Novo Nordisk; Speaker for Astellas, Bayer, Janssen, Lilly, and Phathom; Advisor for Abbott and Bausch/SALIX
Amy Clouse, MD (Planner for Brain Check: Promoting Brain Health): Speaker for Astellas, Stockholder for Eli Lilly and Novo Nordisk
Anelyssa D’Abreu, MD (Planner for Brain Check: Promoting Brain Health): Independent contractor for Biogen, Cognition Therapeutics, Eli Lilly, and Janssen
Andrew Budson (Planner for Brain Check: Promoting Brain Health): Advisor for Eli Lilly and AbbVie, Contractor for Vox Neuro and Bristol Meyers Squibb
All other non-faculty contributors involved in the moderating, planning, development, editing and review of the content have disclosed no relevant financial relationships.